{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T01:24:51Z","timestamp":1752283491774,"version":"3.41.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-025-00968-5","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:22:50Z","timestamp":1736875370000},"page":"493-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Steroid-resistant nephrotic syndrome as paraneoplastic syndrome of Waldenstr\u00f6m macroglobulinemia: a case report"],"prefix":"10.1007","volume":"14","author":[{"given":"Konosuke","family":"Hirano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0965-4997","authenticated-orcid":false,"given":"Sayuri","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichiro","family":"Makinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuomi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ariizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Kanetsuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junki","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"968_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ajh.24557","volume":"92","author":"MA Gertz","year":"2017","unstructured":"Gertz MA. Waldenstr\u00f6m macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017;92:209.","journal-title":"Am J Hematol"},{"key":"968_CR2","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2215\/CJN.03770412","volume":"7","author":"J-F Cambier","year":"2012","unstructured":"Cambier J-F, Ronco P. Onco-Nephrology. Clin J Am Soc Nephrol. 2012;7:1701.","journal-title":"Clin J Am Soc Nephrol"},{"key":"968_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1159\/000063286","volume":"92","author":"S Haraguchi","year":"2002","unstructured":"Haraguchi S, Tomiyoshi Y, Aoki S, Sakemi T. Nephrotic syndrome due to immunologically mediated hypocomplementic glomerulonephritis in a patient of Waldenstrom\u2019s macroglobulinemia. Nephron. 2002;92:452\u20135.","journal-title":"Nephron"},{"key":"968_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MD.0000000000000206","volume":"93","author":"T Kofman","year":"2014","unstructured":"Kofman T, Zhang S-Y, Copie-Bergman C, Moktefi A, Raimbourg Q, Francois H, et al. Minimal change nephrotic syndrome associated with non-hodgkin lymphoid disorders. Medicine. 2014;93:350.","journal-title":"Medicine"},{"key":"968_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12185-018-2430-6","volume":"107","author":"H Miyoshi","year":"2018","unstructured":"Miyoshi H, Ohshima K. Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia\/lymphoma in Japan. Int J Hematol. 2018;107:420.","journal-title":"Int J Hematol"},{"key":"968_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/bjh.12659","volume":"164","author":"D Chihara","year":"2013","unstructured":"Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Brit J Haematol. 2013;164:536.","journal-title":"Brit J Haematol"},{"key":"968_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","volume":"56","author":"PM Ronco","year":"1999","unstructured":"Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355\u201377.","journal-title":"Kidney Int"},{"key":"968_CR8","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","volume":"69","author":"V Audard","year":"2006","unstructured":"Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto J-J, Delmer A, et al. Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006;69:2251\u201360.","journal-title":"Kidney Int"},{"key":"968_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1053\/j.ajkd.2007.06.021","volume":"50","author":"N Aggarwal","year":"2007","unstructured":"Aggarwal N, Batwara R, McCarthy ET, Sharma R, Sharma M, Savin VJ. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease. Am J Kidney Dis. 2007;50:826\u20139.","journal-title":"Am J Kidney Dis"},{"key":"968_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrneph.2010.171","volume":"7","author":"Y-HH Lien","year":"2011","unstructured":"Lien Y-HH, Lai L-W. Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis. Nat Rev Nephrol. 2011;7:85.","journal-title":"Nat Rev Nephrol"},{"key":"968_CR11","doi-asserted-by":"publisher","first-page":"761600","DOI":"10.3389\/fmed.2021.761600","volume":"8","author":"S Purohit","year":"2021","unstructured":"Purohit S, Piani F, Ordo\u00f1ez FA, De Lucas-Collantes C, Bauer C, Cara-Fuentes G. Molecular mechanisms of proteinuria in minimal change disease. Front Med. 2021;8:761600.","journal-title":"Front Med"},{"key":"968_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2215\/CJN.13041117","volume":"13","author":"L Higgins","year":"2018","unstructured":"Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, et al. Kidney involvement of patients with waldenstr\u00f6m macroglobulinemia and other IgM-Producing B Cell lymphoproliferative disorders. Clin J Am Soc Nephrol. 2018;13:1037.","journal-title":"Clin J Am Soc Nephrol"},{"key":"968_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/bjh.14279","volume":"175","author":"JM Vos","year":"2016","unstructured":"Vos JM, Gustine J, Rennke HG, Hunter Z, Manning RJ, Dubeau TE, et al. Renal disease related to Waldenstr\u00f6m macroglobulinaemia: incidence, pathology and clinical outcomes. Br J Haematol. 2016;175:623\u201330.","journal-title":"Br J Haematol"},{"key":"968_CR14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/ndt\/gfy320","volume":"34","author":"NN Uppal","year":"2019","unstructured":"Uppal NN, Monga D, Vernace MA, Mehtabdin K, Shah HH, Bijol V, et al. Kidney diseases associated with Waldenstr\u00f6m macroglobulinemia. Nephrol Dial Transplant. 2019;34:1644\u201352.","journal-title":"Nephrol Dial Transplant"},{"key":"968_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.ajkd.2021.12.014","volume":"80","author":"M Martins","year":"2022","unstructured":"Martins M, Bridoux F, Goujon JM, Meuleman MS, Ribes D, Rondeau E, et al. Complement activation and thrombotic microangiopathy associated with monoclonal gammopathy: a national french case series. Am J Kidney Dis. 2022;80:341\u201352.","journal-title":"Am J Kidney Dis"},{"key":"968_CR16","doi-asserted-by":"publisher","first-page":"780107","DOI":"10.3389\/fimmu.2021.780107","volume":"12","author":"EJ Filippone","year":"2021","unstructured":"Filippone EJ, Newman ED, Li L, Gulati R, Farber JL. Thrombotic microangiopathy, an unusual form of monoclonal gammopathy of renal significance: report of 3 cases and literature review. Front Immunol. 2021;12:780107.","journal-title":"Front Immunol"},{"key":"968_CR17","doi-asserted-by":"publisher","first-page":"823204","DOI":"10.3389\/fimmu.2022.823204","volume":"13","author":"M Colucci","year":"2022","unstructured":"Colucci M, Oniszczuk J, Vivarelli M, Audard V. B-Cell dysregulation in idiopathic nephrotic syndrome: what we know and what we need to discover. Front Immunol. 2022;13:823204.","journal-title":"Front Immunol"},{"key":"968_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/0886022X.2013.832859","volume":"36","author":"C Salviani","year":"2013","unstructured":"Salviani C, Guido G, Serriello I, Giannakakis K, Rocca AR. Renal involvement in Waldenstr\u00f6m\u2019s macroglobulinemia: case report and review of literature. Renal Fail. 2013;36:114.","journal-title":"Renal Fail"},{"key":"968_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.kint.2018.04.024","volume":"94","author":"A Meyrier","year":"2018","unstructured":"Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018;94:861\u20139.","journal-title":"Kidney Int"},{"key":"968_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/bjh.12102","volume":"160","author":"RG Owen","year":"2013","unstructured":"Owen RG, Kyle RA, Stone MJ, Rawstron AC, Leblond V, Merlini G, et al. Response assessment in Waldenstr\u00f6m macroglobulinaemia: update from the VIth International Workshop. Br J Haematol. 2013;160:171\u20136.","journal-title":"Br J Haematol"},{"key":"968_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1053\/j.ajkd.2015.03.035","volume":"66","author":"S Chauvet","year":"2015","unstructured":"Chauvet S, Bridoux F, Ecoti\u00e8re L, Javaugue V, Sirac C, Arnulf B, et al. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients. Am J Kidney Dis. 2015;66:756\u201367.","journal-title":"Am J Kidney Dis"},{"key":"968_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10157-011-0465-6","volume":"15","author":"T Takei","year":"2011","unstructured":"Takei T, Nitta K. Rituximab and minimal change nephrotic syndrome: a therapeutic option. Clin Exp Nephrol. 2011;15:641\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"968_CR23","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","volume":"21","author":"RD Gilbert","year":"2006","unstructured":"Gilbert RD, Hulse E, Rigden S. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediat Nephrol (Berlin, Germany). 2006;21:1698\u2013700.","journal-title":"Pediat Nephrol (Berlin, Germany)"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-00968-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-025-00968-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-00968-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T15:01:33Z","timestamp":1748790093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-025-00968-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["968"],"URL":"https:\/\/doi.org\/10.1007\/s13730-025-00968-5","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no Conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research involved human participants. All procedures performed in studies involving human participants were per the ethical standards of the institutional and\/or national research committee, as well as with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from the patient included in this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}